JNJ — Johnson & Johnson

Health Care · NYSE/Nasdaq. Last price 270.47 USD (+1.25% on the day). Raven's AI 12-month target: 290.00 USD. Updated 2026-11-20.

Paper-trade Johnson & Johnson free with 100 000 fake NOK and compete with other players on Raven Trading Game.

Raven’s AI view

Raven's AI sets a 12-month target of 290.00 USD (+8.56% from 267.14 when it was set on 2026-11-20). Conviction: medium.

Catalysts: New drug approvals/Phase 3 readouts; M&A bolt-on acquisitions

Risks: Litigation cost surprises (talc, opioids); Patent cliff acceleration; Healthcare cost pressure

Earnings

Q3 2026 earnings per share: 2.59 USD against 2.52 expected (beat by 2.7%). EPS estimates for 2026: 11.12 USD (22 analysts), 2027: 11.61 USD (23 analysts). The 2026 estimate has moved +0.6% over 90 days.

Dividends

Johnson & Johnson has paid 5.28 USD per share in dividends over the last 12 months (2.0% yield). Last dividend: 1.34 USD per share, ex-dividend 2026-08-25. Next ex-dividend date: 2026-11-24.

Home · All shares · Leaderboard · News · Learn: stock market courses · AI insights · Raven bot · DNB Markets bot · Mistral bot · Maven bot

More Health Care stocks on NYSE/Nasdaq: ABBV AbbVie · ABT Abbott Laboratories · AMGN Amgen · BMY Bristol-Myers Squibb · CVS CVS Health · DHR Danaher · GILD Gilead Sciences · ISRG Intuitive Surgical

RAVEN is taking longer than usual to load.
RELOAD